BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3320631)

  • 1. [Anetoderma and lupus erythematosus. Study of 2 cases].
    Hassan ML; Schroh RG; Konopka H
    Med Cutan Ibero Lat Am; 1987; 15(4):341-9. PubMed ID: 3320631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anetoderma during antiphospholipid syndrome. 3 cases].
    Disdier P; Christides C; Andrac-Meyer L; Rojat-Habib MC; Aillaud MF; Swiader L; Weiller-Merli C; Berbis P; Harlé JR; Weiller PJ
    Ann Dermatol Venereol; 1996; 123(12):800-3. PubMed ID: 9636765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus.
    Bilen N; Bayramgürler D; Sikar A; Erçin C; Yilmaz A
    Lupus; 2003; 12(9):714-6. PubMed ID: 14514137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of skin disease in patients with lupus erythematosus.
    Callen JP
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):245-64. PubMed ID: 12041952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical images: Anetoderma in systemic lupus erythematosus with antiphospholipid antibodies.
    Venhoff N; Miehle N; Jüttner E; Peter HH; Walker UA
    Arthritis Rheum; 2005 Jul; 52(7):2228. PubMed ID: 15986337
    [No Abstract]   [Full Text] [Related]  

  • 7. Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies.
    Alvarez-Cuesta CC; Raya-Aguado C; Fernández-Rippe ML; Sánchez TS; Pérez-Oliva N
    Dermatology; 2001; 203(4):348-50. PubMed ID: 11752829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies and anetoderma: are they associated?
    Stephansson EA; Niemi KM
    Dermatology; 1995; 191(3):204-9. PubMed ID: 8534938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudotumoral lupus anetoderma. Child chorea. Development over 28 years].
    Schnitzler L; Abimelech PH; Naveau B
    Ann Dermatol Venereol; 1988; 115(6-7):679-84. PubMed ID: 3059943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus-associated anetoderma and anti-phospholipid antibodies.
    Fernández-Galar M; España A; Lloret P
    Clin Exp Dermatol; 2003 Jan; 28(1):39-42. PubMed ID: 12558628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies.
    Montilla C; Alarcón-Segovia D
    Lupus; 2000; 9(7):545-7. PubMed ID: 11035422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
    Magro CM; Dyrsen ME
    J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural findings in the skin lesions of patients with anetoderma.
    Venencie PY; Winkelmann RK; Moore BA
    Acta Derm Venereol; 1984; 64(2):112-20. PubMed ID: 6203297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary cutaneous mucinosis with systemic lupus erythematosus. A case presentation and review of the literature.
    Gammon WR; Caro I; Long JC; Wheeler CE
    Arch Dermatol; 1978 Mar; 114(3):432-5. PubMed ID: 415667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anetoderma and its prothrombotic abnormalities.
    Sparsa A; Piette JC; Wechsler B; Amoura Z; Francès C
    J Am Acad Dermatol; 2003 Dec; 49(6):1008-12. PubMed ID: 14639377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
    Reefman E; de Jong MC; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2006; 8(6):R156. PubMed ID: 17014704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular vasculitis in systemic lupus erythematosus.
    Westers-Attema A; van Tubergen A; Plasschaert H; van Marion AM; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2008 Nov; 47 Suppl 1():3-6. PubMed ID: 18986475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic abnormalities associated with primary anetoderma.
    Hodak E; Shamai-Lubovitz O; David M; Hazaz B; Katzenelson-Weissman V; Lahav M; Sandbank M
    Arch Dermatol; 1992 Jun; 128(6):799-803. PubMed ID: 1599266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jadassohn-Pellizzari anetoderma: study of multiphoton microscopy based on two-photon excited fluorescence and second harmonic generation.
    Zhao J; Chen J; Yang Y; Zhuo S; Jiang X; Tian W; Ye X; Lin L; Xie S
    Eur J Dermatol; 2009; 19(6):570-5. PubMed ID: 19737728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.